GlassScriptPhysician profile
Aynur Okcay
NPI 1922319607
$13,742.23
in general payments reported to CMS, 2019-2025
12 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Sleep Medicine (Family Medicine) provider received nationally (typical 2025 total: $557).
See the full distribution for Sleep Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $357 · 2021: $831 · 2022: $888 · 2023: $2,767 · 2024: $8,282 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,244 · Food and Beverage: $3,593 · Travel and Lodging: $2,153 · Education: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,244.00 |
| Food and Beverage | $3,593.06 |
| Travel and Lodging | $2,153.21 |
| Education | $297.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $7,983.48 | 2019-2024 | Xywav |
| Zoll Respicardia, INC. | $2,220.37 | 2019-2023 | Remede System |
| Inspire Medical Systems, INC. | $1,721.50 | 2021-2024 | Inspire |
| Harmony Biosciences LLC | $1,051.87 | 2020-2025 | Wakix |
| Watermark Medical, INC. | $246.00 | 2021 | |
| Idorsia Pharmaceuticals US INC | $193.02 | 2023-2024 | Quviviq |
| Arbor Pharmaceuticals, INC. | $106.65 | 2019-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $91.13 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $51.03 | 2024 | Sunosi |
| Itamar Medical INC | $32.29 | 2021-2023 | Watchpatone |
| Almatica Pharma LLC | $31.54 | 2023 | Loreev Xr |
| Eisai INC. | $13.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aynur Okcay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.